An episode of the "Joe Rogan Experience" podcast, seen by more than 10 million, appears to have reignited interest in the ...

UPMC Hillman Cancer Center in central Pennsylvania has approximately 40,000 patient visits for medical oncology and infusion ...

New York City-based Weill Cornell has established a cancer research collaborative to explore ways to improve the ...

Karen Knudsen, PhD, has been appointed CEO of San Francisco-based Parker Institute for Cancer Immunotherapy. Dr. Knudsen previously served as CEO for both the American Cancer Society and ACS Cancer ...

Yunu, creator of the industry’s first end-to-end clinical trial imaging workflow platform supporting sites, CROs and pharma, ...

Misinformation about ivermectin as a cancer treatment is on the rise, with social media and public figures fueling false ...

The long-term impact of disruptions in oncology care during the COVID-19 pandemic will become more apparent in the coming years, according to Dan Nardi, MS, of Reimagine Care.

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

The firm's artificial intelligence-based biomarker tools including Lunit Scope IO and Lunit Scope Universal IHC will be available across trials at the Center for Cancer Research.

In high doses, ivermectin can be toxic and cause central nervous system problems like blurred vision, confusion and seizures, ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on immunotherapy.